ChemBK
  • Home
  • Product Category


10448-96-1

Almestrone

CAS: 10448-96-1

Molecular Formula: C19H24O2

  1. Home
  2. Product Category
  3. Organic raw materials
  4. Ketones
  5. 10448-96-1

10448-96-1 - Names and Identifiers

Name Almestrone
Synonyms U 24704
SR 16279
NSC 134712
Almestrone
7alpha-Methylestrone
3-hydroxy-7-methylestra-1,3,5(10)-trien-17-one
3-Hydroxy-7a-methylestra-1,3,5(10)-trien-17-one
3-Hydroxy-7α-methylestra-1,3,5(10)-trien-17-one
3-Hydroxy-7alpha-methylestra-1,3,5(10)-trien-17-one
(7alpha)-3-hydroxy-7-methylestra-1,3,5(10)-trien-17-one
Estra-1,3,5(10)-trien-17-one,3-hydroxy-7-Methyl-, (7a)-
(7R,8R,9S,13S,14S)-3-hydroxy-7,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
CAS 10448-96-1
InChI InChI=1/C19H24O2/c1-11-9-12-10-13(20)3-4-14(12)15-7-8-19(2)16(18(11)15)5-6-17(19)21/h3-4,10-11,15-16,18,20H,5-9H2,1-2H3

10448-96-1 - Physico-chemical Properties

Molecular FormulaC19H24O2
Molar Mass284.39
Density1.127±0.06 g/cm3(Predicted)
Melting Point231-233 °C
Boling Point448.7±45.0 °C(Predicted)
Flash Point191.2°C
Vapor Presure1.14E-08mmHg at 25°C
pKa10.25±0.60(Predicted)
Refractive Index1.57

10448-96-1 - Introduction

Ameestrone (also known as a nonsteroidal antiestrogen) is a chemical compound with antiestrogenic activity. It is an organic compound with a chemical formula of C20H19NO2 and a molecular weight of 297.37g/mol.

The main properties of Ameestrone include high stability and anti-estrogenic effects. It acts as a non-steroidal antiestrogen that inhibits the action of estrogen by interfering with the binding of the Estrolane receptor (estrogen receptor). Because of its anti-estrogen activity, it can be used to treat some diseases that rely on estrogen growth, such as breast cancer, endometriosis, etc.

Ameestrone has various preparation methods, and the common methods include chemical synthesis and biological transformation. The method of chemical synthesis can be through acetophenone as raw material through ketone reduction, ketone acidification, esterification and other reactions to obtain almeestrone. The method of bioconversion is the metabolic transformation of a suitable substrate by a microbial strain to obtain Ameestrone.

For safety information, Ameestrone is generally prescribed for clinical use. In general, it is relatively safe in appropriate dosage, but it is still necessary to pay attention to potential side effects and contraindications during use. Common side effects include breast discomfort, menstrual irregularities, and dizziness. In addition, the use of Ameestrone is prohibited during pregnancy and should be used in consultation with a professional doctor. For special groups such as lactating women, children, etc., also need to be used carefully, and under the guidance of a doctor.
Last Update:2024-04-10 22:29:15
10448-96-1
Supplier List
Shanghai Amole Biotechnology Co., Ltd.
Spot supply
Product Name: Almestrone Request for quotation
CAS: 10448-96-1
Tel: 400-968-2212
Email: 3623107365@qq.com
Mobile: 18916960931
QQ: 3623107365 Click to send a QQ message
Wechat: 18916960931
SKYRUN INDUSTRIAL CO.,LTD
Spot supply
Product Name: Almestrone Visit Supplier Webpage Request for quotation
CAS: 10448-96-1
Tel: +86 0571-86722205
Email: sales@chinaskyrun.com
Mobile: +8618958170122
QQ: 2531159185 Click to send a QQ messageSend QQ message
Wechat: chinaskyrun
Shanghai Amole Biotechnology Co., Ltd.
Spot supply
Product Name: Almestrone Request for quotation
CAS: 10448-96-1
Tel: 400-968-2212
Email: 3623107365@qq.com
Mobile: 18916960931
QQ: 3623107365 Click to send a QQ message
Wechat: 18916960931
SKYRUN INDUSTRIAL CO.,LTD
Spot supply
Product Name: Almestrone Visit Supplier Webpage Request for quotation
CAS: 10448-96-1
Tel: +86 0571-86722205
Email: sales@chinaskyrun.com
Mobile: +8618958170122
QQ: 2531159185 Click to send a QQ messageSend QQ message
Wechat: chinaskyrun
View History
10448-96-1
benzoylurea
181231-66-3
砷酸银
230615-52-8
39917-38-9
81624-55-7
2125668-23-5
137156-41-3
22476-74-0
  • Home
  • Product Category

© 2015, 2023 ChemBK.com All Rights Reserved | Build: 20230617001